NAMI
COGT icon

Nomura Asset Management International’s Cogent Biosciences COGT Stock Holding History

Nomura Asset Management International’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
392,484
+38,244
+11% +$1.34M 0.02% 665
2026
Q1 		$13.6M Buy
354,240
+48,300
+16% +$1.78M 0.02% 636
2025
Q4 		$10.9M Buy
+305,940
New +$8.6M 0.02% 691

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nomura Asset Management International's COGT Position: Q2 2026 in Review

Nomura Asset Management International increased its Cogent Biosciences (COGT) stake by 11% in Q2 2026, buying an estimated $1.34M and bringing the position to 392,484 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #665.

Nomura Asset Management International first reported a position in COGT in Q4 2025 and has held it in 3 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Nomura Asset Management International held 392,484 shares of Cogent Biosciences worth $15.2M as of Q2 2026.
  • Nomura Asset Management International bought 38,244 Cogent Biosciences shares in Q2 2026, an estimated $1.34M.
  • Cogent Biosciences made up 0.02% of Nomura Asset Management International's portfolio in Q2 2026, its #665 holding.
  • Nomura Asset Management International first reported a position in Cogent Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.